Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 10, 2026The Journal of Sexual Medicine

(028) Monitored Hormone Therapy for Sexual Dysfunction in Menopausal Breast Cancer Survivors: Are Benefits Greater than Risks?

View Full Paper
Ask AI
Bookmark
Share

Authors

BVB ValerioKKK KoontzMNM Neustein

Discussion

Loading...

Member takes

Overview

Chart review demonstrates improved sexual function in menopausal breast cancer survivors using monitored hormone therapy, suggesting beneficial outcomes despite risks.

Key Points

  • To evaluate the benefits and risks of monitored hormone therapy in menopausal breast cancer survivors experiencing sexual dysfunction.
  • Conducted a chart review from 2007 to 2025.
  • Performed biopsychosocial assessments and hormone blood tests.
  • Administered various hormone treatments including estradiol, progesterone, and testosterone.
  • Conducted regular monitoring of hormone levels and vulvoscopic examinations.
  • 100% of patients reported symptom improvement on hormone therapy.
  • Mean follow-up of 3.7 years with significant changes in sexual health scores.
  • No major adverse events reported, only one breast cancer recurrence.

Cite This Study

Valerio et al. (2026) studied this question.

synapsesocial.com/papers/69d8967d6c1944d70ce07e69https://doi.org/10.1093/jsxmed/qdag063.028
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1(024) Monitored Hormone Therapy in Women 70 Years and Older: Aging Does Not Mean Sexual Retirement2026
  2. 2(288) Menopausal and Sexual Symptom Management and Treatment Utilization Patterns Among Young Breast Cancer Survivors2026
  3. 3Menopausal hormone therapy and breast cancer: risk and management2026 · 1 citations
  4. 4Menopausal hormone therapy for breast cancer patients: what is the current evidence?2025 · 8 citations
  5. 5Menopausal hormone therapy and comprehensive postmenopausal care in gynecologic cancer survivors: A position paper from the FIGO Committee on Women at Menopausal Age2026